rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-2-10
|
pubmed:abstractText |
To investigate the effects of interferon beta treatment on T-cell tumor necrosis factor alpha (TNF-alpha) binding (which is a possible marker for T-cell-dependent immune function) in patients with multiple sclerosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0003-9942
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9923763-Adjuvants, Immunologic,
pubmed-meshheading:9923763-Adolescent,
pubmed-meshheading:9923763-Adult,
pubmed-meshheading:9923763-Age of Onset,
pubmed-meshheading:9923763-Binding, Competitive,
pubmed-meshheading:9923763-Case-Control Studies,
pubmed-meshheading:9923763-Female,
pubmed-meshheading:9923763-Humans,
pubmed-meshheading:9923763-Interferon-beta,
pubmed-meshheading:9923763-Male,
pubmed-meshheading:9923763-Middle Aged,
pubmed-meshheading:9923763-Multiple Sclerosis,
pubmed-meshheading:9923763-Protein Binding,
pubmed-meshheading:9923763-Recurrence,
pubmed-meshheading:9923763-Remission Induction,
pubmed-meshheading:9923763-T-Lymphocytes,
pubmed-meshheading:9923763-Tumor Necrosis Factor-alpha
|
pubmed:year |
1999
|
pubmed:articleTitle |
Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis.
|
pubmed:affiliation |
Department of Neurosciences, University of Pisa, Italy. Bongioanni@sssupl.sssup.it
|
pubmed:publicationType |
Journal Article
|